Amgen Aktie
262,80
EUR
+2,05
EUR
+0,79
%
271,90
USD
-0,35
USD
-0,13
%
nachbörslich
Werbung
Amgen Aktie Analyse
| 28.04.21 | Amgen buy | Goldman Sachs Group Inc. | |
| 28.04.21 | Amgen Neutral | JP Morgan Chase & Co. | |
| 04.03.21 | Amgen buy | Goldman Sachs Group Inc. | |
| 04.03.21 | Amgen Neutral | JP Morgan Chase & Co. | |
| 23.12.20 | Amgen Sector Perform | RBC Capital Markets | |
| 28.07.20 | Amgen Neutral | JP Morgan Chase & Co. | |
| 24.01.20 | Amgen Neutral | JP Morgan Chase & Co. | |
| 21.05.19 | Amgen Sector Perform | RBC Capital Markets | |
|
Werbung
|
|||
| 15.03.19 | Amgen Outperform | BMO Capital Markets | |
| 01.02.19 | Amgen Sector Perform | RBC Capital Markets | |
| 30.01.19 | Amgen Neutral | JP Morgan Chase & Co. | |
| 17.01.19 | Amgen Sector Perform | RBC Capital Markets | |
| 17.01.19 | Amgen buy | Goldman Sachs Group Inc. | |
| 14.01.19 | Amgen Sector Perform | RBC Capital Markets | |
| 07.12.18 | Amgen buy | Goldman Sachs Group Inc. | |
| 04.12.18 | Amgen buy | Goldman Sachs Group Inc. | |
| 04.12.18 | Amgen overweight | Morgan Stanley | |
| 04.12.18 | Amgen Sector Perform | RBC Capital Markets | |
| 04.12.18 | Amgen Neutral | JP Morgan Chase & Co. | |
| 04.12.18 | Amgen Neutral | Cantor Fitzgerald | |
| 04.12.18 | Amgen Equal weight | Barclays Capital | |
| 04.12.18 | Amgen buy | Jefferies & Company Inc. | |
| 01.11.18 | Amgen Sector Perform | RBC Capital Markets | |
| 31.10.18 | Amgen overweight | Morgan Stanley | |
| 31.10.18 | Amgen Sector Perform | RBC Capital Markets | |
| 31.10.18 | Amgen buy | Goldman Sachs Group Inc. | |
| 25.10.18 | Amgen Neutral | JP Morgan Chase & Co. | |
| 12.10.18 | Amgen buy | Goldman Sachs Group Inc. | |
| 09.10.18 | Amgen Neutral | JP Morgan Chase & Co. | |
| 05.10.18 | Amgen buy | Jefferies & Company Inc. | |
| 04.10.18 | Amgen Neutral | Cantor Fitzgerald | |
| 02.10.18 | Amgen Outperform | Oppenheimer & Co. Inc. | |
| 01.10.18 | Amgen buy | Jefferies & Company Inc. | |
| 01.10.18 | Amgen Neutral | Cantor Fitzgerald | |
| 28.09.18 | Amgen Sector Perform | RBC Capital Markets | |
| 10.09.18 | Amgen Sector Perform | RBC Capital Markets | |
| 10.09.18 | Amgen buy | Jefferies & Company Inc. | |
| 10.09.18 | Amgen Outperform | Oppenheimer & Co. Inc. | |
| 06.09.18 | Amgen buy | Jefferies & Company Inc. | |
| 29.08.18 | Amgen neutral | Wells Fargo & Co | |
| 28.08.18 | Amgen Outperform | Oppenheimer & Co. Inc. | |
| 24.08.18 | Amgen buy | Jefferies & Company Inc. | |
| 30.07.18 | Amgen Neutral | RBC Capital Markets | |
| 30.07.18 | Amgen Outperform | Oppenheimer & Co. Inc. | |
| 30.07.18 | Amgen neutral | Wells Fargo & Co | |
| 30.07.18 | Amgen Hold | Morningstar | |
| 27.07.18 | Amgen buy | Jefferies & Company Inc. | |
| 27.07.18 | Amgen Outperform | RBC Capital Markets | |
| 27.07.18 | Amgen buy | Goldman Sachs Group Inc. | |
| 13.07.18 | Amgen overweight | Morgan Stanley | |
Werbung